On October 6, Stryker fell 3.55% in pre-market trading, trading at $280.00/share, with Turnover of $203.15 million.

Within the Health Care Equipment sector where Stryker belongs, individual stock performances are mixed. Among them, Medtronic PLC up 0.06%, Abbott Laboratories up 0.19%, Intuitive Surgical up 0.34%, Boston Scientific up 0.28%, and IDEXX Laboratories unchanged.

Stryker Corporation operates as a medical technology company through two segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for hip and knee joint replacements, trauma and extremities surgeries, as well as spinal implant products. The MedSurg and Neurotechnology segment offers surgical equipment, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, reprocessed medical devices, and neurotechnology products for minimally invasive procedures, stroke treatment, and craniomaxillofacial implants.

Stryker has not yet released a specific announcement directly explaining the current pre-market decline. Upcoming earnings are scheduled for October 29, with an expected EPS of $3.6.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)